Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st New Schizophrenia Drug in Decades
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.
In a Victory for the Free Market, FDA Approves New Schizophrenia Drug
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.
BioWorld
1h
US FDA clears Cobenfy, first new schizophrenia drug in decades
The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...
The Washington Post
1d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
“This drug takes the first new approach to
schizophrenia
treatment in decades,” Tiffany Farchione, director of
FDA
’s ...
Medscape
8h
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
High-end brothel plea
Helene: How to help
'Harry Potter' star dies
Stadiums to serve as shelters
Troops to leave some bases
Promotes watch collection
Targeted Black residents?
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
Meta hit with privacy fine
Heads to US-Mexico border
Ending password-sharing
Chinese submarine sank
More executives leave
Producing doc on Diddy
Boxes to distribute Narcan
Fake Biden robocalls fine
WI duplicate ballot flap
Pleads not guilty
Urgent safety alert for 737s
On Secret Service failures
NC board removes 747K
NIH finds misconduct
ISR targets Hezbollah HQ
US charges three Iranians
Fed inflation gauge cools
Related topics
Food and Drug Administration
Bristol-Myers Squibb
Cobenfy
Feedback